Roscovitine (Seliciclib,CYC202)

    
99%

Roscovitine (Seliciclib,CYC202)

源叶(MedMol)
S80493 一键复制产品信息
186692-46-6
C19H26N6O
354.45
MFCD02266401
6-(苄基氨基)-2(R)-[[1-(羟甲基)丙基]氨基]-9-异丙基嘌呤
货号 规格 价格 上海 北京 武汉 南京 购买数量
S80493-2mg 99% ¥136.00 2 - - -
S80493-5mg 99% ¥238.00 >10 - - -
S80493-10mg 99% ¥421.60 >10 - - -
S80493-25mg 99% ¥646.00 货期:2-3天 - - -
S80493-50mg 99% ¥952.00 >10 - - -
S80493-100mg 99% ¥1292.00 货期:2-3天 - - -
S80493-200mg 99% ¥2244.00 货期:2-3天 - - -
S80493-250mg 99% ¥2584.00 货期:2-3天 - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品

产品介绍

Seliciclib (Roscovitine) is an orally bioavailable and selective CDKs inhibitor with IC50s of 0.2 μM, 0.65 μM, and 0.7 μM for CDK5, Cdc2, and CDK2, respectively.

产品描述: Seliciclib (Roscovitine) is an orally bioavailable and selective CDKs inhibitor with IC50s of 0.2 μM, 0.65 μM, and 0.7 μM for CDK5, Cdc2, and CDK2, respectively.
靶点: cdc2/cyclin B:0.65 μM (IC50);cdk2/cyclin A:0.7 μM (IC50);Cdk2/cyclin E2:0.7 μM (IC50);CDK5/p35:0.16 μM (IC50);GST-erk1:30 μM (IC50);erk1:34 μM (IC50);erk2:14 μM (IC50);IR tyrosine kinase:70 μM (IC50);CDK
体内研究: Compare with normal controls, Seliciclib (Roscovitine) downregulates phosphorylated ERK1/2 and PPARγ with concomitant increase in E-cadherin, but decrease in Vimentin and Collagen IV. Correspondingly, Seliciclib decreases renal tubulointerstitial fibrosis of diabetic rats. Seliciclib (Roscovitine) is effective in decreasing tubulointerstitial fibrosis via the ERK1/2/PPARγ pathway in diabetic rats. Seliciclib (Roscovitine) (16.5 mg/kg) significantly reduces the rate of tumor growth and increases survival of treated mice. Strikingly, Seliciclib (Roscovitine) treatment leads to complete tumor disappearance in one mouse (25%); moreover, no tumor regrowth in this mouse is found 5 months after completion of the treatment. Mouse weights do not differ significantly between mice treated with Seliciclib and control mice, and behavioral differences between the two groups are also negligible. These results suggest that Seliciclib can be used effectively as a selective tumor growth inhibitor in HPV+ head and neck cancer
参考文献: 1. Meijer L, et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem. 1997 Jan 15;243(1-2):527-36. 2. Bai X, et al. CDK5 promotes renal tubulointerstitial fibrosis in diabetic nephropathy via erk1/2/pparγ pathway. Oncotarget. 2016 Apr 27. 3. Gary C, et al. Selective antitumor activity of roscovitine in head and neck cancer. Oncotarget. 2016 May 23.
溶解性: DMSO  :  ≥  100  mg/mL  (282.13  mM)
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.821 ml 14.106 ml 28.213 ml
5 mM 0.564 ml 2.821 ml 5.643 ml
10 mM 0.282 ml 1.411 ml 2.821 ml
50 mM 0.056 ml 0.282 ml 0.564 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×

相关产品